As of 9:30 AM on the 26th, SK Chemicals is trading at 117,500 KRW, up 3.07% from the previous day. The trading volume is 783,771 shares, which is about 21.75% of the previous day's volume. SK Chemicals is known as a manufacturer of eco-friendly materials, energy, and biopharmaceuticals.

On June 23, researcher Ha Tae-gi from Sangsangin Securities stated, "With the clinical progress of the new drug candidates developed by the company, there is expected to be a stock price momentum in the second half of the year. First, the value of the pneumococcal vaccine pipeline is increasing. Second, domestic clinical trials for the COVID-19 vaccine are scheduled around September. The company was selected as a COVID-19 vaccine developer in Korea and is currently in preclinical stages with a recombinant antigen vaccine. The pneumococcal pipeline is approaching Phase 2 clinical trials, and the September clinical trial entry of the COVID-19 vaccine will act as a stock price momentum. The expected strong performance in the second quarter is also a positive factor for the stock price." He set the target price for SK Chemicals at 120,000 KRW.

Over the past five days, individual investors have net sold 209,776 shares of SK Chemicals, while foreigners and institutions have net bought 81,599 shares and 125,990 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing